ARM Ischaemia Study
Acute upper limb ischaemia (AULI) is a critical vascular emergency characterised by the abrupt loss of arterial blood flow to the upper extremities. Timely revascularisation, ideally within 6 hours, is crucial, especially when motor or sensory dysfunction is present. While surgical/endovascular intervention remains the conventional approach, patients with less severe presentations may sometimes respond to medical management alone.
To date, no randomised controlled trials have compared the treatment methods for patients with acute upper limb ischaemia. Effective management of AULI is highly contingent upon assessing the ischemic severity and pinpointing the etiological factors at play. The European Society for Vascular Surgery (ESVS) 2020 Guidelines recommend conservative management with anticoagulation for certain patients, though this requires careful monitoring to avoid progression.
Introducing the ARMIES Study
To address the current evidence gap in AULI management, the multicentre service evaluation project ‘ARMIES’ will be launched. This study aims to evaluate current treatment strategies and clinical outcomes against the ESVS guidelines, comparing data with international benchmarks. The study will provide valuable insights into the incidence of AULI, the treatment modalities employed, patient outcomes, and associated risk factors, ultimately enhancing care standards for this serious condition.
The full project protocol is available here
Registration is now open
Data collection for this international, multicentre study starts on the 7th of October
By joining ARMIES you are contributing to a global effort to refine and improve treatment strategies for AULI and will receive collaborative authorship opportunities.
Sign up today via the link below or if you have any questions please get in contact with the ARMIES team at armies.vern@gmail.com.